Zoar (ZOAR) closed at $4.36 on November 19, 2026, down 31.8% from the previous close, on volume of 24,256 shares (30-day average 43,564).
Data as of November 19, 2026.
Zoar Limited Completes Business Combination and Becomes Wholly Owned Subsidiary
TipRanks (Wed, 18-Nov 10:27 AM ET)
Zoar Limited Completes Business Combination with Impact Biomedical Inc.
Business Wire (Wed, 18-Nov 8:00 AM ET)
Zoar Ltd is a pharmaceutical company that specializes in the development, manufacturing and distribution of APIs and intermediates. It provides contract development and manufacturing organization (CDMO) services for complex APIs and intermediates used in specialized therapeutic areas. Its services include chemical composition analysis, formulation development, API and intermediate manufacturing, and quality control. The company works with contract manufacturing organizations (CMOs) for manufacturing activities.
Zoar trades on the AMEX stock market under the symbol ZOAR.
As of November 19, 2026, ZOAR stock price declined to $4.36 with 24,256 million shares trading.
ZOAR has a market cap of $784.80 million. This is considered a Small Cap stock.
ZOAR support price is $6.39 and resistance is $6.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ZOAR shares will trade within this expected range on the day.